Market Cap 110.34M
Revenue (ttm) 2.27M
Net Income (ttm) -83.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,681.94%
Debt to Equity Ratio 0.00
Volume 114,500
Avg Vol 139,948
Day's Range N/A - N/A
Shares Out 9.39M
Stochastic %K 24%
Beta 2.45
Analysts Strong Sell
Price Target $108.22

Company Profile

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. Its lead product candidate is KRRO-110 which is in Phase 1/2 clinical trial for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The c...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 468 1999
Address:
One Kendall Square, Building 600-700 Suite 6-401, Cambridge, United States
tamem60
tamem60 Jun. 25 at 2:29 AM
0 · Reply
stephllllll
stephllllll Jun. 10 at 2:50 PM
0 · Reply
KingJellyBean69
KingJellyBean69 Jun. 3 at 7:32 PM
$WOLF $KRRO is the next one for me, primed for launch
0 · Reply
KingJellyBean69
KingJellyBean69 Jun. 3 at 7:32 PM
$LVWR $KRRO is the next one for me, this one goes wild when it does !
0 · Reply
_www_larval_com_
_www_larval_com_ Jun. 3 at 6:08 PM
$KRRO has jumped 5% higher to 24% (~913Kv) in the last few minutes, follow for more volatility.
0 · Reply
TheLand330
TheLand330 Jun. 2 at 2:16 PM
$KRRO crazy volume already!
0 · Reply
wahoowa96
wahoowa96 May. 31 at 3:34 PM
$KRRO I find it very interesting for RNA to be edited to fix a deficiency in a gene. I have positions in VERV and ARCT. ARCT-032 supply entire length of mRNA for fixing deficient cftr grne by tecnically doing protein replacement. VERV-301 is gene editing to LP(a) to lower genetically driven high cholesterol... it's a one time DNA efitor. They all use LNP. Because i am closely following DMD gene therapy. I was thinking helthy mRNA Dystrophin gene supplied to muscle cell was way to go. But if you can find locations of mutant genes then just edit those RNA genes prior to translation it will be great too...No risks to dna mishandling and upside to do combination with protein replacement gene therapy. Just getting interested in RNA editing tech.
2 · Reply
Estimize
Estimize May. 21 at 8:01 PM
Wall St is expecting -2.57 EPS for $KRRO Q2 [Reporting 08/19 AMC] http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_c
0 · Reply
BipoIarBear
BipoIarBear May. 14 at 4:17 PM
$SEPN will be new $KRRO
1 · Reply
JarvisFlow
JarvisFlow May. 13 at 10:30 PM
Chardan Capital has adjusted their stance on Korro Bio ( $KRRO ), setting the rating to Buy with a target price of 25.
0 · Reply
Latest News on KRRO
Korro to Participate in Upcoming Investor Conferences

May 14, 2025, 4:05 PM EDT - 5 weeks ago

Korro to Participate in Upcoming Investor Conferences


Korro to Present at the Jefferies London Healthcare Conference

Nov 14, 2024, 8:00 AM EST - 7 months ago

Korro to Present at the Jefferies London Healthcare Conference


Korro Announces $70 Million Private Placement

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Korro Announces $70 Million Private Placement


Korro Bio Appoints Dr. Rachel Meyers to Board of Directors

Nov 28, 2023, 8:00 AM EST - 1 year ago

Korro Bio Appoints Dr. Rachel Meyers to Board of Directors


Korro Bio and Frequency Therapeutics Announce Merger Agreement

Jul 14, 2023, 6:30 AM EDT - 2 years ago

Korro Bio and Frequency Therapeutics Announce Merger Agreement


tamem60
tamem60 Jun. 25 at 2:29 AM
0 · Reply
stephllllll
stephllllll Jun. 10 at 2:50 PM
0 · Reply
KingJellyBean69
KingJellyBean69 Jun. 3 at 7:32 PM
$WOLF $KRRO is the next one for me, primed for launch
0 · Reply
KingJellyBean69
KingJellyBean69 Jun. 3 at 7:32 PM
$LVWR $KRRO is the next one for me, this one goes wild when it does !
0 · Reply
_www_larval_com_
_www_larval_com_ Jun. 3 at 6:08 PM
$KRRO has jumped 5% higher to 24% (~913Kv) in the last few minutes, follow for more volatility.
0 · Reply
TheLand330
TheLand330 Jun. 2 at 2:16 PM
$KRRO crazy volume already!
0 · Reply
wahoowa96
wahoowa96 May. 31 at 3:34 PM
$KRRO I find it very interesting for RNA to be edited to fix a deficiency in a gene. I have positions in VERV and ARCT. ARCT-032 supply entire length of mRNA for fixing deficient cftr grne by tecnically doing protein replacement. VERV-301 is gene editing to LP(a) to lower genetically driven high cholesterol... it's a one time DNA efitor. They all use LNP. Because i am closely following DMD gene therapy. I was thinking helthy mRNA Dystrophin gene supplied to muscle cell was way to go. But if you can find locations of mutant genes then just edit those RNA genes prior to translation it will be great too...No risks to dna mishandling and upside to do combination with protein replacement gene therapy. Just getting interested in RNA editing tech.
2 · Reply
Estimize
Estimize May. 21 at 8:01 PM
Wall St is expecting -2.57 EPS for $KRRO Q2 [Reporting 08/19 AMC] http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_c
0 · Reply
BipoIarBear
BipoIarBear May. 14 at 4:17 PM
$SEPN will be new $KRRO
1 · Reply
JarvisFlow
JarvisFlow May. 13 at 10:30 PM
Chardan Capital has adjusted their stance on Korro Bio ( $KRRO ), setting the rating to Buy with a target price of 25.
0 · Reply
Armonica423
Armonica423 May. 10 at 8:22 PM
$KRRO Big exposure at 3 oncology conferences this coming week, do your dd research
1 · Reply
JarvisFlow
JarvisFlow May. 8 at 11:30 AM
HC Wainwright & Co. updates rating for Korro Bio ( $KRRO ) to Buy, target set at 115 → 100.
0 · Reply
Estimize
Estimize May. 7 at 9:15 PM
$KRRO reported -2.49 EPS and 2.55 revenue for Q1. http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_content=KRRO&utm_
0 · Reply
FreeMoneyandFed
FreeMoneyandFed May. 7 at 1:46 PM
$KRRO every biotech co is struggling and small ones are announcing layoffs. In last several months many bios have been reducing staff. Its so difficult to find job for new graduates this year in this industry !
0 · Reply
Sillyspuh
Sillyspuh May. 2 at 5:21 PM
$KRRO Guess this is just on its way back up
0 · Reply
Sillyspuh
Sillyspuh Apr. 23 at 2:43 PM
$KRRO Why the big run today? Didn't see any news on their site.
0 · Reply
kshonstocks
kshonstocks Apr. 22 at 6:56 PM
$KRRO thru 20 dma and sector has been better
0 · Reply
TheLand330
TheLand330 Apr. 17 at 8:37 PM
$NVDA Keep an eye on $KRRO!!!! It’s gonna blow up very soon!!
0 · Reply
TheLand330
TheLand330 Apr. 17 at 8:36 PM
$KRRO This is brewing!!!!!!!
0 · Reply
JarvisFlow
JarvisFlow Apr. 16 at 11:30 AM
Chardan Capital has adjusted their stance on Korro Bio ( $KRRO ), setting the rating to Buy with a target price of 25.
0 · Reply
Flowjob
Flowjob Apr. 4 at 2:07 PM
$KRRO more room to fall GLTA.
1 · Reply
ngie66a
ngie66a Mar. 26 at 5:07 PM
$AGMH This is only the beginning of what's to come. $INMB $AKTX $KRRO $BALY
0 · Reply